These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5431475)
1. Fibrous dysplasia of the bone and high cardiac output. Fischer JA; Bollinger A; Lichtlen P; Wellauer J Am J Med; 1970 Jul; 49(1):140-6. PubMed ID: 5431475 [No Abstract] [Full Text] [Related]
2. Normophosphatemic vitamin D-resistant osteomalacia in a patient with normal calcium and fat absorption. Waron M; Stauffer M; Baylink D; Rich C Ann Intern Med; 1971 Sep; 75(3):415-9. PubMed ID: 5568153 [No Abstract] [Full Text] [Related]
3. [Physiopathology of osteoporosis in the young adult]. Bordier P; de Sèze S; Miravet L; Berbir N Sem Hop; 1974 Jan; 50(3):197-206. PubMed ID: 4367925 [No Abstract] [Full Text] [Related]
8. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover. Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355 [No Abstract] [Full Text] [Related]
9. [A case of polyostotic fibrous dysplasia (Albright syndrome) with gynecomastia and hyperestrogenism]. Buzási G; Juhász J; Fehér L Endokrinologie; 1967; 52(3):145-52. PubMed ID: 5589132 [No Abstract] [Full Text] [Related]
10. Quantitative histology of bone in hyperparathyroidism. Its relation to clinical features, x-ray, and biochemistry. Byers PD; Smith R Q J Med; 1971 Oct; 40(160):471-86. PubMed ID: 5157405 [No Abstract] [Full Text] [Related]
13. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications. Long A; Loughlin T; Towers RP; McKenna TJ Ir J Med Sci; 1988 Jul; 157(7):229-34. PubMed ID: 2971632 [No Abstract] [Full Text] [Related]
14. Effect of parathyroid hormone on bone resorption in uremic patients. Arata RO; Campos C; Mautalen CA Medicina (B Aires); 1976; 36(2):113-20. PubMed ID: 933833 [No Abstract] [Full Text] [Related]
15. Fibrous dysplasia associated with sickle-cell disease. Report of a case with a discussion of the multiple factors affecting both conditions. Brighton CT; Muehe CC Clin Orthop Relat Res; 1967; 55():151-7. PubMed ID: 6079746 [No Abstract] [Full Text] [Related]
16. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Liens D; Delmas PD; Meunier PJ Lancet; 1994 Apr; 343(8903):953-4. PubMed ID: 7909013 [TBL] [Abstract][Full Text] [Related]
18. Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D. Smith R; Dick M Clin Sci; 1968 Feb; 34(1):43-56. PubMed ID: 5640685 [No Abstract] [Full Text] [Related]
19. The osteomalacia syndrome after stomach operations. Morgan DB; Hunt G; Paterson CR Q J Med; 1970 Jul; 39(155):395-410. PubMed ID: 5478508 [No Abstract] [Full Text] [Related]
20. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Isaia GC; Lala R; Defilippi C; Matarazzo P; Andreo M; Roggia C; Priolo G; de Sanctis C Calcif Tissue Int; 2002 Aug; 71(2):121-8. PubMed ID: 12200645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]